0001698998-22-000001.txt : 20220308
0001698998-22-000001.hdr.sgml : 20220308
20220308192356
ACCESSION NUMBER: 0001698998-22-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220306
FILED AS OF DATE: 20220308
DATE AS OF CHANGE: 20220308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woolson Daniel
CENTRAL INDEX KEY: 0001698998
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 22723410
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC., 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-03-06
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001698998
Woolson Daniel
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
VP, GM-Infusion Capital
Common Stock
2022-03-06
4
M
0
1444
0.0
A
9606
D
Common Stock
2022-03-06
4
F
0
639
242.93
D
8967
D
Common Stock
2022-03-06
4
M
0
1418
0.0
A
10385
D
Common Stock
2022-03-06
4
F
0
628
0.0
D
9757
D
Common Stock
2022-03-08
4
M
0
2020
0.0
A
11777
D
Common Stock
2022-03-08
4
F
0
894
0.0
D
10883
D
Common Stock
0.0
2022-03-07
4
A
0
2897
0.0
A
2025-03-07
Common Stock
2897
2897
D
Common Stock
2022-03-06
4
M
0
1444
0.0
D
2022-03-06
Common Stock
1444
0
D
Performance Shares
0.0
2022-03-08
4
M
0
2020
0.0
D
2024-03-08
Common Stock
2020
4040
D
Performance Shares
2022-03-06
4
M
0
1418
0.0
D
2023-03-06
Common Stock
1418
1417
D
These Securities are Performance-based Restricted Stock Units (PRSU).
These securities are Restricted Stock Units.
There is neither a purchase price nor an exercise price for the Restricted Stock Units.
One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
These are restricted stock units that fully vest 3 years from the grant date.
There is neither a purchase price nor an exercise price for the PRSUs.
These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
These PRSUs were granted on March 6, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
By: Paula Darbyshire, Attorney-in-fact For: Daniel Woolson
2022-03-08